The Bio Report
Levine Media Group
The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
Get every episode summarized
Each time The Bio Report publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Is this your show?
Claim it: a verified badge, every new episode summarised to your inbox, and first say over how it is presented here.
Episodes (1239)
Using AI Created Digital Twins to Accelerate Clinical Trials
The Bio Report
Modulating RNA to Quell Disease
The Bio Report
A Quest to Extend Life through Early Disease Detection
The Bio Report
Modulating a Gatekeeper of Cellular Metabolism to Treat a Range of Diseases
The Bio Report
Finding the Best Cell for the Job
The Bio Report
Transforming Clinical Trials with Digital Technology
The Bio Report
Designing Immunotherapies that Can Overcome Recurrence and Resistance
The Bio Report
Extending Precision Medicine Beyond Cancer
The Bio Report
Growing Biologics
The Bio Report
An Experimental COVID-19 Vaccine Begins Human Clinical Trials
The Bio Report
Speeding the Delivery of CAR-T Therapies While Cutting the Cost
The Bio Report
Transforming Infused Biologics into Injectables
The Bio Report
A Novel Approach to NASH That May Have Benefits for COVID 19 As Well
The Bio Report
Will a Focus on Protein Dysregulation Help Prothena Break from the Fold
The Bio Report
After FDA Set Back, AI Driven Drug Company Advances with New CEO
The Bio Report
A Gamified Therapy System Helps People with Brain Injury Recover
The Bio Report
Genentech Drug Offers Oral, at-Home Option for SMA Patients
The Bio Report
Enabling Precision Medicine through Proteomics
The Bio Report
Battling Drug-Resistant Fungal Infections
The Bio Report
Making Colorectal Cancer Screening Less of a Pain in the Ass
The Bio Report
Targeting Diseases of Aging at a Cellular Level
The Bio Report
Cracking the Immune System with AI
The Bio Report
Using AI to Improve Drug Companies’ Regulatory Performance
The Bio Report
Delivering Biologics Orally
The Bio Report
Turning Proteins into Device Coatings that Provide Therapeutic Benefits
The Bio Report
Testing if an Approved Antiviral May Prevent COVID-19 Outbreaks
The Bio Report
Using AI to Crack COVID-19
The Bio Report
Why An Experimental Therapy for Inflammatory Disorders Could Help the Fight Agai...
The Bio Report
Modernizing Phage Therapy to Kill Multidrug-Resistant Bacteria
The Bio Report
A Rare Disease Drug Hunter Turns His Attention to COVID-19
The Bio Report
What It Will Take to Move Beyond the Pandemic
The Bio Report
Reading, Writing, and Erasing the Way to Epigenetic Cancer Therapies
The Bio Report
Better Immunotherapies Through Chemistry
The Bio Report
Bringing the Trial to the Patient
The Bio Report
Controlling the Activity of Cell and Gene Therapies with Precision
The Bio Report
Why Soon-Shiong Thinks His Triangle Offense for Cancer Can Be Applied to COVID-1...
The Bio Report
COVID-19, Vaccine Development, and Global Health Lessons from Ebola
The Bio Report
Improving Cancer Outcomes with Early Diagnosis
The Bio Report
Making A Social Contract That’s Enforceable
The Bio Report
Treating Alzheimer’s Disease as an Autoimmune Condition
The Bio Report
Fishing for New Drugs
The Bio Report
Thoughts on the State of the Antimicrobial Arsenal
The Bio Report
A MedTech Company That Thinks Like a Biopharma
The Bio Report
Tapping the Potential of Psychedelics to Treat Psychiatric Conditions
The Bio Report
Quantifying Neurodegeneration with Precision
The Bio Report
Orasis Developing Eye Drops as Alternative to Reading Glasses
The Bio Report
Reversing Disease Signals
The Bio Report
Turning Cold Tumors Hot
The Bio Report
Stabilizing Neuronal Connections to Treat Cognitive Impairment in Alzheimer’s
The Bio Report
Our Annual Biotech Review/Preview with STAT’s Adam Feuerstein
The Bio Report